LONG-TERM TREATMENT WITH RITUXIMAB IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSIS: OUR CLINICAL EXPERIENCE

被引：0
|
作者：
Lumetti, F. [1 ]
Spinella, A. [1 ]
Ariani, A. [2 ]
Cocchiara, E. [1 ]
Colaci, M. [3 ]
Silva, M. [4 ]
Sverzellati, N. [4 ]
Ferri, C. [1 ]
Salvarani, C. [1 ]
Giuggioli, D. [1 ]
机构：
[1] Univ Modena & RE, Scleroderma Unit, Chair Rheumatol, Modena, Italy
[2] Univ Parma, Dept Med, Internal Med & Rheumatol Unit, Azienda Osped, Parma, Italy
[3] Univ Catania, Cannizzaro Hosp, Internal Med Unit, Catania, Italy
[4] Univ Parma, Sect Radiol, Dept Clin Sci, Parma, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.6052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0442
引用
收藏
页码：750 / 751
页数：2
相关论文
共 50 条
  • [1] LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS: UPDATE OF OUR CLINICAL EXPERIENCE
    Lumetti, F.
    Colaci, M.
    Esposito, C.
    Cocchiara, E.
    Vacchi, C.
    Spinella, A.
    Tiengo, G.
    Giuggioli, D.
    Ferri, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 634 - 635
  • [2] A BENEFICIAL EFFECT OF LONG-TERM TREATMENT OF RITUXIMAB IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Ananyeva, Lidia
    Koneva, Olga
    Garzanova, Liudmila
    Starovoytova, Mayya
    Desinova, Oxana
    Ovsyannikova, Olga
    Shayakhmetova, Rushana
    CHEST, 2022, 162 (04) : 2178A - 2178A
  • [3] Interstitial lung disease in systemic sclerosis - Our experience
    Gunawardena, H.
    Charmichael, C.
    Foley, N. M.
    McHugh, N. J.
    RHEUMATOLOGY, 2006, 45 : I152 - I152
  • [4] Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
    Mohammed, Abdel Gaffar A.
    Alshihre, Ammar
    Al-Homood, Ibrahim Abdulrazag
    ANNALS OF THORACIC MEDICINE, 2017, 12 (04) : 294 - 297
  • [5] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
    Hughes, Michael
    Denton, Christopher P.
    Khanna, Dinesh
    RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
  • [6] Meta-analysis of rituximab treatment of systemic sclerosis related interstitial lung disease
    Harrington, Robert
    Conway, Richard
    Fahy, Ruairi
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
    Andersson, Helena
    Sem, Marthe
    Lund, May Brit
    Aalokken, Trond Mogens
    Gunther, Anne
    Walle-Hansen, Ragnhild
    Garen, Torhild
    Molberg, Oyvind
    RHEUMATOLOGY, 2015, 54 (08) : 1420 - 1428
  • [8] LONG-TERM OUTCOMES OF AFRICAN AMERICAN PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE
    Volkmann, Elizabeth
    Ning, Li
    Khanna, Dinesh
    Clements, Philip
    Furst, Daniel
    Assassi, Shervin
    Roth, Michael
    Elashoff, Robert
    Tashkin, Donald
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1808 - 1808
  • [9] LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE TREATED WITH RITUXIMAB
    Desinova, Oxana
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    CHEST, 2021, 160 (04) : 1188A - 1188A
  • [10] Efficacy of Rituximab in Systemic Sclerosis with Interstitial Lung Disease
    Onat, Ahmet Mesut
    Zengin, Orhan
    Aksoy, Savas
    Onder, Mustafa Erkut
    Sacinti, Koray Gorkem
    Kisacik, Bunyamin
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345